Asian Spectator

Men's Weekly

.

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

  • Written by ACN Newswire - Press Releases

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

SHANGHAI, CHINA, Jul 20, 2020 - (ACN Newswire) - Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and best-in-class therapies, today announced that it has successfully closed US$97 million in Series C financing.

The...

More Articles ...

  1. Top 7 Benefits That a CBD-Rich Oil Can Potentially Offer
  2. Australians concerned about their financial wellbeing as a result of COVID-19
  3. Fivetran Raises $100 Million to Accelerate Growth as Automated Data Integration Leader
  4. Commodities Intelligence Centre (CIC) introduces international Trade Data and Business Services, partners SBF to drive digital transformation of Singapore SMEs

Magazine

PBB sebut dunia memasuki era kebangkrutan air, tanda-tandanya sudah nyata

Di tengah perubahan iklim, dunia masih saja menggunakan air tawar dalam jumlah yang sangat besar. Akibatnya, kita mencapai titik yang disebut sebagai era kebangkrutan air. Banyak wilayah kini tidak la...

Transisi energi berkeadilan dimulai dari suaramu. Isi survei sekarang!

Isu transisi energi bukan cuma urusan pemerintah atau ahli kebijakan. Perubahan cara kita memproduksi dan menggunakan energi tentu membentuk arah ekonomi ke depan, mulai dari jenis lapangan kerja yang...

Menghilang 50.000 tahun lalu, riset ungkap apa yang terjadi pada habitat para ‘hobbit’ Flores

_Homo floresiensis_ skull.Wikimedia Commons, CC BY-SASekitar 50 ribu tahun lalu, umat manusia kehilangan salah satu kerabat hominin terakhirnya, Homo floresiensis—yang dijuluki “hobbit&rdq...